↓ Skip to main content

PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
43 Mendeley
Title
PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma
Published in
Cancer Immunology, Immunotherapy, November 2019
DOI 10.1007/s00262-019-02426-5
Pubmed ID
Authors

Xiaoli Liu, Mengge Li, Xinhui Wang, Zhibo Dang, Yuyong Jiang, Xianbo Wang, Yaxian Kong, Zhiyun Yang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 12%
Student > Bachelor 5 12%
Other 4 9%
Student > Master 4 9%
Student > Ph. D. Student 3 7%
Other 5 12%
Unknown 17 40%
Readers by discipline Count As %
Medicine and Dentistry 10 23%
Immunology and Microbiology 6 14%
Biochemistry, Genetics and Molecular Biology 4 9%
Nursing and Health Professions 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 1 2%
Unknown 20 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2022.
All research outputs
#4,676,206
of 23,426,104 outputs
Outputs from Cancer Immunology, Immunotherapy
#477
of 2,930 outputs
Outputs of similar age
#93,140
of 361,196 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#9
of 45 outputs
Altmetric has tracked 23,426,104 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,930 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,196 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.